Intramuscular Drug Delivery Market Report

Global Intramuscular Drug Delivery Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：214
  • REPORT CODE：GMM872764
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intramuscular Drug Delivery market report explains the definition, types, applications, major countries, and major players of the Intramuscular Drug Delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Galaxo

    • Pharmajet

    • Eli Lily

    • Antares Pharma

    • Novartis

    • HMD pharmaceuticals

    • Merck

    • Pfizer

    • Pacira Pharmaceuticals

    • Inovio Pharmaceuticals

    • Teva Pharmaceutical

    By Type:

    • Drug Molecule

    • Delivery Devices

    By End-User:

    • Infectious Disease

    • Oncology

    • Autoimmune Diseases

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Intramuscular Drug Delivery Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Intramuscular Drug Delivery Outlook to 2028- Original Forecasts

    • 2.2 Intramuscular Drug Delivery Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Intramuscular Drug Delivery Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Intramuscular Drug Delivery Market- Recent Developments

    • 6.1 Intramuscular Drug Delivery Market News and Developments

    • 6.2 Intramuscular Drug Delivery Market Deals Landscape

    7 Intramuscular Drug Delivery Raw Materials and Cost Structure Analysis

    • 7.1 Intramuscular Drug Delivery Key Raw Materials

    • 7.2 Intramuscular Drug Delivery Price Trend of Key Raw Materials

    • 7.3 Intramuscular Drug Delivery Key Suppliers of Raw Materials

    • 7.4 Intramuscular Drug Delivery Market Concentration Rate of Raw Materials

    • 7.5 Intramuscular Drug Delivery Cost Structure Analysis

      • 7.5.1 Intramuscular Drug Delivery Raw Materials Analysis

      • 7.5.2 Intramuscular Drug Delivery Labor Cost Analysis

      • 7.5.3 Intramuscular Drug Delivery Manufacturing Expenses Analysis

    8 Global Intramuscular Drug Delivery Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Intramuscular Drug Delivery Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Intramuscular Drug Delivery Export by Region (Top 10 Countries) (2017-2028)

    9 Global Intramuscular Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Intramuscular Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Drug Molecule Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Delivery Devices Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intramuscular Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Intramuscular Drug Delivery Market Analysis and Outlook till 2022

    • 10.1 Global Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.2.2 Canada Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.2.3 Mexico Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.2 UK Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.3 Spain Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.4 Belgium Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.5 France Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.6 Italy Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.7 Denmark Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.8 Finland Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.9 Norway Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.10 Sweden Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.11 Poland Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.12 Russia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.3.13 Turkey Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.2 Japan Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.3 India Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.4 South Korea Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.5 Pakistan Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.6 Bangladesh Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.7 Indonesia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.8 Thailand Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.9 Singapore Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.10 Malaysia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.11 Philippines Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.4.12 Vietnam Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.2 Colombia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.3 Chile Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.4 Argentina Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.5 Venezuela Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.6 Peru Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.7 Puerto Rico Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.5.8 Ecuador Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.6.2 Kuwait Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.6.3 Oman Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.6.4 Qatar Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.7.2 South Africa Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.7.3 Egypt Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.7.4 Algeria Intramuscular Drug Delivery Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Intramuscular Drug Delivery Consumption (2017-2022)

      • 10.8.2 New Zealand Intramuscular Drug Delivery Consumption (2017-2022)

    11 Global Intramuscular Drug Delivery Competitive Analysis

    • 11.1 Galaxo

      • 11.1.1 Galaxo Company Details

      • 11.1.2 Galaxo Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Galaxo Intramuscular Drug Delivery Main Business and Markets Served

      • 11.1.4 Galaxo Intramuscular Drug Delivery Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pharmajet

      • 11.2.1 Pharmajet Company Details

      • 11.2.2 Pharmajet Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pharmajet Intramuscular Drug Delivery Main Business and Markets Served

      • 11.2.4 Pharmajet Intramuscular Drug Delivery Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Eli Lily

      • 11.3.1 Eli Lily Company Details

      • 11.3.2 Eli Lily Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Eli Lily Intramuscular Drug Delivery Main Business and Markets Served

      • 11.3.4 Eli Lily Intramuscular Drug Delivery Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Antares Pharma

      • 11.4.1 Antares Pharma Company Details

      • 11.4.2 Antares Pharma Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Antares Pharma Intramuscular Drug Delivery Main Business and Markets Served

      • 11.4.4 Antares Pharma Intramuscular Drug Delivery Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Intramuscular Drug Delivery Main Business and Markets Served

      • 11.5.4 Novartis Intramuscular Drug Delivery Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 HMD pharmaceuticals

      • 11.6.1 HMD pharmaceuticals Company Details

      • 11.6.2 HMD pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 HMD pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

      • 11.6.4 HMD pharmaceuticals Intramuscular Drug Delivery Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Merck

      • 11.7.1 Merck Company Details

      • 11.7.2 Merck Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Merck Intramuscular Drug Delivery Main Business and Markets Served

      • 11.7.4 Merck Intramuscular Drug Delivery Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Intramuscular Drug Delivery Main Business and Markets Served

      • 11.8.4 Pfizer Intramuscular Drug Delivery Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pacira Pharmaceuticals

      • 11.9.1 Pacira Pharmaceuticals Company Details

      • 11.9.2 Pacira Pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

      • 11.9.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Inovio Pharmaceuticals

      • 11.10.1 Inovio Pharmaceuticals Company Details

      • 11.10.2 Inovio Pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

      • 11.10.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Teva Pharmaceutical

      • 11.11.1 Teva Pharmaceutical Company Details

      • 11.11.2 Teva Pharmaceutical Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Main Business and Markets Served

      • 11.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Intramuscular Drug Delivery Market Outlook by Types and Applications to 2028

    • 12.1 Global Intramuscular Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Drug Molecule Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Delivery Devices Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Intramuscular Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Intramuscular Drug Delivery Market Analysis and Outlook to 2028

    • 13.1 Global Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.2.2 Canada Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.2 UK Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.3 Spain Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.5 France Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.6 Italy Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.8 Finland Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.9 Norway Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.11 Poland Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.12 Russia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.2 Japan Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.3 India Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.3 Chile Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.6 Peru Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.3 Oman Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Intramuscular Drug Delivery Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Intramuscular Drug Delivery Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Intramuscular Drug Delivery

    • Figure of Intramuscular Drug Delivery Picture

    • Table Global Intramuscular Drug Delivery Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Intramuscular Drug Delivery Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Drug Molecule Consumption and Growth Rate (2017-2022)

    • Figure Global Delivery Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Table North America Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Canada Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Mexico Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure Germany Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure UK Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Spain Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Belgium Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure France Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Italy Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Denmark Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Finland Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Norway Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Sweden Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Poland Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Russia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Turkey Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table APAC Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure China Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Thailand Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Singapore Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Philippines Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table South America Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure Brazil Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Colombia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Chile Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Argentina Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Peru Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table GCC Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure Bahrain Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Oman Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Qatar Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Africa Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure Nigeria Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Africa Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Egypt Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Algeria Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Oceania Intramuscular Drug Delivery Consumption by Country (2017-2022)

    • Figure Australia Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Intramuscular Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Galaxo Company Details

    • Table Galaxo Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galaxo Intramuscular Drug Delivery Main Business and Markets Served

    • Table Galaxo Intramuscular Drug Delivery Product Portfolio

    • Table Pharmajet Company Details

    • Table Pharmajet Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmajet Intramuscular Drug Delivery Main Business and Markets Served

    • Table Pharmajet Intramuscular Drug Delivery Product Portfolio

    • Table Eli Lily Company Details

    • Table Eli Lily Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lily Intramuscular Drug Delivery Main Business and Markets Served

    • Table Eli Lily Intramuscular Drug Delivery Product Portfolio

    • Table Antares Pharma Company Details

    • Table Antares Pharma Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Antares Pharma Intramuscular Drug Delivery Main Business and Markets Served

    • Table Antares Pharma Intramuscular Drug Delivery Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Intramuscular Drug Delivery Main Business and Markets Served

    • Table Novartis Intramuscular Drug Delivery Product Portfolio

    • Table HMD pharmaceuticals Company Details

    • Table HMD pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table HMD pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

    • Table HMD pharmaceuticals Intramuscular Drug Delivery Product Portfolio

    • Table Merck Company Details

    • Table Merck Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Intramuscular Drug Delivery Main Business and Markets Served

    • Table Merck Intramuscular Drug Delivery Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Intramuscular Drug Delivery Main Business and Markets Served

    • Table Pfizer Intramuscular Drug Delivery Product Portfolio

    • Table Pacira Pharmaceuticals Company Details

    • Table Pacira Pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacira Pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

    • Table Pacira Pharmaceuticals Intramuscular Drug Delivery Product Portfolio

    • Table Inovio Pharmaceuticals Company Details

    • Table Inovio Pharmaceuticals Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inovio Pharmaceuticals Intramuscular Drug Delivery Main Business and Markets Served

    • Table Inovio Pharmaceuticals Intramuscular Drug Delivery Product Portfolio

    • Table Teva Pharmaceutical Company Details

    • Table Teva Pharmaceutical Intramuscular Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Intramuscular Drug Delivery Main Business and Markets Served

    • Table Teva Pharmaceutical Intramuscular Drug Delivery Product Portfolio

    • Figure Global Drug Molecule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Delivery Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Table North America Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Germany Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure China Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Brazil Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Intramuscular Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure Australia Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Intramuscular Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US